Short Retraction Notice This article has been retracted to straighten the academic record. In making this decision the Editorial Board follows COPE's Retraction Guidelines . The aim is to promote the circulation of scientific research by offering an ideal research publication platform with due consideration of internationally accepted standards on publication ethics. The Editorial Board would like to extend its sincere apologies for any inconvenience this retraction may have caused. The full retraction notice in PDF is preceding the original paper, which is marked "RETRACTED".
KeywordsBronchopulmonary DysplasiaPreterm InfantsProtection and TherapyMesenchymal Stem CellsGut Microbiota
Poindexter, B.B., Feng, R., Schmidt, B., et al. (2015) Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. Annals of the American Thoracic Society , 12, 1822-1830. https://doi.org/10.1513/AnnalsATS.201504-218OC
Perrone, S., Tataranno, M.L. and Buonocore, G. (2012) Oxidative Stress and Bronchopulmonary Dysplasia. Journal of Clinical Neonatology , 1, 109-114. https://doi.org/10.4103/2249-4847.101683
Eichenwald, E.C. and Stark, A.R. (2008) Management and Outcomes of Very Low Birth Weight. The New England Journal of Medicine , 358, 1700-1711. https://doi.org/10.1056/NEJMra0707601
Jobe, A.H. and Bancalari, E. (2001) Bronchopulmonary Dysplasia. American Jou r nal of Respiratory and Critical Care Medicine , 163, 1723-1729. https://doi.org/10.1164/ajrccm.163.7.2011060
Higgins, R.D., Jobe, A.H., Koso-Thomas, M., et al. (2018) Bronchopulmonary Dysplasia: Executive Summary of a Workshop. The Journal of Pediatrics , 197, 300-308. https://doi.org/10.1016/j.jpeds.2018.01.043
Kim, F., Bateman, D.A., Goldshtrom, N., et al. (2021) Revisiting the Definition of Bronchopulmonary Dysplasia in Premature Infants at a Single Center Quaternary Neonatal Intensive Care Unit. Journal of Perinatology , 41, 756-763. https://doi.org/10.1038/s41372-021-00980-4
Husain, A.N., Siddiqui, N.H. and Stocker, J.T. (1998) Pathology of Arrested Acinar Development in Postsurfactant Bronchopulmonary Dysplasia. Human Pathology , 29, 710-717. https://doi.org/10.1016/S0046-8177(98)90280-5
Ma, L., Zhou, P., Neu, J. and Lin, H.C. (2017) Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia. Paediatric Respiratory Reviews , 22, 83-88. https://doi.org/10.1016/j.prrv.2016.08.013
Thille, A.W., Esteban, A., Fernández-Segoviano, P., et al. (2013) Comparison of the Berlin Definition for Acute Respiratory Distress Syndrome with Autopsy. American Journal of Respiratory and Critical Care Medicine , 187, 761-767. https://doi.org/10.1164/rccm.201211-1981OC
Kalikkot Thekkeveedu, R., El-Saie, A., Prakash, V., et al. (2022) Ventilation-Induced Lung Injury (VILI) in Neonates: Evidence-Based Concepts and Lung-Protective Strategies. Journal of Clinical Medicine , 11, Article 557. https://doi.org/10.3390/jcm11030557
Coalson, J.J. (2003) Pathology of New Bronchopulmonary Dysplasia. Seminars in Fetal and Neonatal Medicine , 8, 73-81. https://doi.org/10.1016/S1084-2756(02)00193-8
Ferrero, D.M., Larson, J., Jacobsson, B., et al. (2016) Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations But Provides No Biologic Explanation for 2/3 of All Preterm Births. PLOS ONE , 11, e0162506. https://doi.org/10.1371/journal.pone.0162506
Goldenberg, R.L., Culhane, J.F., Iams, J.D., et al. (2008) Epidemiology and Causes of Preterm Birth. Lancet , 371, 75-84. https://doi.org/10.1016/S0140-6736(08)60074-4
Liggins, G.C. and Howie, R.N. (1972) A Controlled Trial of Antepartum Glucocorticoid Treatment for Prevention of the Respiratory Distress Syndrome in Premature Infants. Pediatrics , 50, 515-525. https://doi.org/10.1542/peds.50.4.515
Venkatesh, V.C. and Katzberg, H.D. (1997) Glucocorticoid Regulation of Epithelial Sodium Channel Genes in Human Fetal Lung. American Journal of Physiology - Lung Cellular and Molecular Physiolog , 273, L227-L233. https://doi.org/10.1152/ajplung.1997.273.1.L227
Ballard, P.L. (2000) Scientifific Rationale for the Use of Antenatal Glucocorticoids to Promote Fetal Development. NeoReviews , 1, e83-e90. https://doi.org/10.1542/neo.1-5-e83
Millage, A.R., Latuga, M.S. AND Aschner, J.L. (2017) Effffect of Perinatal Glucocorticoids on Vascular Health and Disease. Pediatric Research , 81, 4-10. https://doi.org/10.1038/pr.2016.188
Haviv, H.R., Said, J. AND Mol, B.W. (2019) The Place of Antenatal Corticosteroids in Late Preterm and Early Term Births. Seminars in Fetal and Neonatal Medicine , 24, 37-42. https://doi.org/10.1016/j.siny.2018.10.001
Roberts, D., Brown, J., Medley, N., et al. (2017) Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. Cochrane D a tabase of Systematic Reviews , 3, CD004454. https://doi.org/10.1002/14651858.CD004454.pub3
McGoldrick, E., Stewart, F., Parker, R., et al. (2020) Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. Cochrane Database of Systematic Reviews , 3, CD004454. https://doi.org/10.1002/14651858.CD004454.pub4
Travers, C.P., Carlo, W.A., McDonald, S.A., et al. (2018) Mortality and Pulmonary Outcomes of Extremely Preterm Infants Exposed to Antenatal Corticosteroids. American Journal of Obstetrics and Gynecolo gy , 218, 130.e1-130.e13. https://doi.org/10.1016/j.ajog.2017.11.554
Doyle, L.W. (2021) Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia. Neonatology , 118, 244-251. https://doi.org/10.1159/000515950
Avery, G.B., Fletcher, A.B., Kaplan, M., et al. (1985) Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia. P e diatrics , 75, 106-111. https://doi.org/10.1542/peds.75.1.106
Doyle, L.W., Cheong, J.L., Ehrenkranz, R.A., et al. (2017) Early ( Cochrane Database of Systematic Reviews , 10, CD001146. https://doi.org/10.1002/14651858.CD001145.pub4
Doyle, L.W., Cheong, J.L., Ehrenkranz, R.A., et al. (2017) Late (>7 Days) Systemic Postnatal Corticosteroids for Prevention of Bronchopulmonary Dysplasia in Preterm Infants. Cochrane Database of Systematic Reviews , 10, CD001145. https://doi.org/10.1002/14651858.CD001145.pub4
Yuksel, B. and Greenough, A. (1992) Randomised Trial of Inhaled Steroids in Preterm Infants with Respiratory Symptoms at Follow Up. Thorax , 47, 910-913. https://doi.org/10.1136/thx.47.11.910
Bassler, D., Plavka, R., Shinwell, E.S., et al. (2015) Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. The New England Journal of Med i cine , 373, 1497-1506. https://doi.org/10.1056/NEJMoa1501917
Nelin, L.D. and Logan, J.W. (2017) The Use of Inhaled Corticosteroids in Chronically Ventilated Preterm Infants. Seminars in Fetal and Neonatal Medicine , 22, 296-301. https://doi.org/10.1016/j.siny.2017.07.005
Shah, S.S., Ohlsson, A., Halliday, H.L., et al. (2017) Inhaled versus Systemic Corticosteroids for the Treatment of Bronchopulmonary Dysplasia in Ventilated Very Low Birth Weight Preterm Infants. Cochrane Database of Systematic Reviews , 10, CD002057. https://doi.org/10.1002/14651858.CD002057.pub4
Hunt, K.A., Dassios, T., Ali, K. and Greenough, A. (2018) Prediction of Bronchopulmonary Dysplasia Development. ADC Fetal & Neonatal Edition , 103, F598-F599. https://doi.org/10.1136/archdischild-2018-315343
Sweet, D.G., Carnielli, V., Greisen, G., et al. (2019) European Consensus Guidelines on the Management of Respiratory Distress Syndrome—2019 Update. Neonatology , 115, 432-450. https://doi.org/10.1159/000499361
Webb, H.H. and Tierney, D.F. (1974) Experimental Pulmonary Edema Due to Intermittent Positive Pressure Ventilation with High Inflation Pressures. Protection by Positive End-Expiratory Pressure. American Review of Respiratory Disease , 110, 556-565.
Slutsky, A.S. and Ranieri, V.M. (2013) Ventilator-Induced Lung Injury. The New England Journal of Medicine , 369, 2126-2136. https://doi.org/10.1056/NEJMra1208707
Schmölzer, G.M., Kumar, M., Pichler, G., et al. (2013) Non-Invasive versus Invasive Respiratory Support in Preterm Infants at Birth: Systematic Review and Meta-Analysis. BMJ , 347, f5980. https://doi.org/10.1136/bmj.f5980
Behnke, J., Lemyre, B., Czernik, C., et al. (2019) Non-Invasive Ventilation in Neonatology. Deutsches Ärzteblatt International , 116, 177-183. https://doi.org/10.3238/arztebl.2019.0177
Carlton, D.P., Cummings, J.J., Scheerer, R.G., et al. (1990) Lung Overexpansion Increases Pulmonary Microvascular Protein Permeability in Young Lambs. Journal of Applied Physiology , 69, 577-583. https://doi.org/10.1152/jappl.1990.69.2.577
Mokres, L.M., Parai, K., Hilgendorff, A., et al. (2010) Prolonged Mechanical Ventilation with Air Induces Apoptosis and Causes Failure of Alveolar Septation and Angiogenesis in Lungs of Newborn Mice. American Journal of Physiology - Lung Cellular and Molecular Physiology , 298, L23-L35. https://doi.org/10.1152/ajplung.00251.2009
Wada, K., Jobe, A.H. and Ikegami, M. (1997) Tidal Volume Effects on Surfactant Treatment Responses with the Initiation of Ventilation in Preterm Lambs. Journal of Applied Physiology , 83, 1054-1061. https://doi.org/10.1152/jappl.1997.83.4.1054
Lista, G., Colnaghi, M., Castoldi, F., et al. (2004) Impact of Targeted-Volume Ventilation on Lung Inflammatory Response in Preterm Infants with Respiratory Distress Syndrome (RDS). Pediatric Pulmonology , 37, 510-514. https://doi.org/10.1002/ppul.10458
Jain, D. and Bancalari, E. (2019) New Developments in Respiratory Support for Preterm Infants. American Journal of Perinatology , 36, S13-S17. https://doi.org/10.1055/s-0039-1691817
Peng, W., Zhu, H., Shi, H. and Liu, E.M. (2014) Volume-Targeted Ventilation Is More Suitable than Pressure-Limited Ventilation for Preterm Infants: A Systematic Review and Meta-Analysis. ADC Fetal & Neonatal Edition , 99, F158-F165. https://doi.org/10.1136/archdischild-2013-304613
Klingenberg, C., Wheeler, K.I., McCallion, N., et al. (2017) Volume-Targeted Versus Pressure-Limited Ventilation in Neonates. Cochrane Database of Systematic Reviews , 10, CD003666. https://doi.org/10.1002/14651858.CD003666.pub4
Cannavò, L., Rulli, I., Falsaperla, R., et al. (2020) Ventilation, Oxidative Stress and Risk of Brain Injury in Preterm Newborn. Italian Journal of Pediatrics , 46, Article No. 100. https://doi.org/10.1186/s13052-020-00852-1
Navalesi, P. and Longhini, F. (2015) Neurally Adjusted Ventilatory Assist. Current Opinion in Critical Care , 21, 58-64. https://doi.org/10.1097/MCC.0000000000000167
Protain, A.P., Firestone, K.S., McNinch, N.L. and Stein, H.M. (2021) Evaluating Peak Inspiratory Pressures and Tidal Volume in Premature Neonates on NAVA Ventilation. European Journal of Pediatrics , 180, 167-175. https://doi.org/10.1007/s00431-020-03728-y
Rosterman, J.L., Pallotto, E.K., Truog, W.E., et al. (2018) The Impact of Neurally Adjusted Ventilatory Assist Mode on Respiratory Severity Score and Energy Expenditure in Infants: A Randomized Crossover Trial. Journal of Perinatology , 38, 59-63. https://doi.org/10.1038/jp.2017.154
Jung, Y.H., Kim, H.S., Lee, J., et al. (2016) Neurally Adjusted Ventilatory Assist in Preterm Infants with Established or Evolving Bronchopulmonary Dysplasia on Highintensity Mechanical Ventilatory Support: A Single-Center Experience. Pedi a tric Critical Care Medicine , 17, 1142-1146. https://doi.org/10.1097/PCC.0000000000000981
Shetty, S., Evans, K., Cornuaud, P., et al. (2021) Neurally Adjusted Ventilatory Assist in Very Prematurely Born Infants with Evolving/Established Bronchopulmonary Dysplasia. American Journal of Perinatology Reports , 11, e127-e131. https://doi.org/10.1055/s-0041-1739458
Soll, R.F. (2000) Synthetic Surfactant for Respiratory Distress Syndrome in Preterm Infants. Cochrane Database of Systematic Reviews , 3, CD001149. https://doi.org/10.1002/14651858.CD001149
Bahadue, F.L. and Soll, R. (2012) Early Versus Delayed Selective Surfactant Treatment for Neonatal Respiratory Distress Syndrome. Cochrane Database of Systema t ic Reviews , 11, CD001456. https://doi.org/10.1002/14651858.CD001456.pub2
Rigo, V., Lefebvre, C. and Broux, I. (2016) Surfactant Instillation in Spontaneously Breathing Preterm Infants: A Systematic Review and Meta-Analysis. European Journal of Pediatrics , 175, 1933-1942. https://doi.org/10.1007/s00431-016-2789-4
Cummings, J.J., Gerday, E., Minton, S., et al. (2020) Aerosolized Calfactant for Newborns with Respiratory Distress: A Randomized Trial. Pediatrics , 146, e20193967. https://doi.org/10.1542/peds.2019-3967
Aranda, J.V., Gorman, W., Bergsteinsson, H., et al. (1977) Effiffifficacy of Caffffeine in Treatment of Apnea in the Low-Birth-Weight Infant. The Journal of Pediatrics , 90, 467-472. https://doi.org/10.1016/S0022-3476(77)80718-X
Abu-Shaweesh, J.M. and Martin, R.J. (2017) Caffffeine Use in the Neonatal Intensive Care Unit. Seminars in Fetal and Neonatal Medicine , 22, 342-347. https://doi.org/10.1016/j.siny.2017.07.011
Davis, J.M., Bhutani, V.K., Stefano, J.L., et al. (1989) Changes in Pulmonary Mechanics Following Caffffeine Administration in Infants with Bronchopulmonary Dysplasia. Pediatric Pulmonology , 6, 49-52. https://doi.org/10.1002/ppul.1950060112
Schmidt, B., Roberts, R.S., Davis, P., et al. (2006) Caffeine Therapy for Apnea of Prematurity. The New England Journal of Medicine , 354, 2112-2121. https://doi.org/10.1056/NEJMoa054065
Davis, P.G., Schmidt, B., Roberts, R.S., et al. (2010) Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups. The Journal of Pediatrics , 156, 382-387. https://doi.org/10.1016/j.jpeds.2009.09.069
Lodha, A., Seshia, M., McMillan, D.D., et al. (2015) Association of Early Caffeine Administration and Neonatal Outcomes in Very Preterm Neonates. JAMA Pedi a tr ics , 169, 33-38. https://doi.org/10.1001/jamapediatrics.2014.2223
Papoffff, P., Cerasaro, C., Caresta, E., et al. (2012) Current Strategies for Treating Infants with Severe Bronchopulmonary Dysplasia. The Journal of Maternal-Fetal & Neonatal Medicine , 25, 15-20. https://doi.org/10.3109/14767058.2012.712352
Berkelhamer, S.K., Mestan, K.K. and Steinhorn, R.H. (2013) Pulmonary Hypertension in Bronchopulmonary Dysplasia. Seminars in Perinatology , 37, 124-131. https://doi.org/10.1053/j.semperi.2013.01.009
Berger, S. and Konduri, G.G. (2006) Pulmonary Hypertension in Children: The Twenty-Fifirst Century. Pediatric Clinics of North America , 53, 961-967. https://doi.org/10.1016/j.pcl.2006.08.001
Ter Horst, S.A.J., Walther, F.J., Poorthuis, B.J.H.M., et al. (2007) Inhaled Nitric Oxide Attenuates Pulmonary Inflammation and Fifibrin Deposition and Prolongs Survival in Neonatal Hyperoxic Lung Injury. American Journal of Physiology - Lung Cellular and Molecular Physiology , 293, L35-L44. https://doi.org/10.1152/ajplung.00381.2006
Banks, B.A., Seri, I., Ischiropoulos, H., et al. (1999) Changes in Oxygenation with Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia. Pediatrics , 103, 610-618. https://doi.org/10.1542/peds.103.3.610
Barrington, K.J., Finer, N. and Pennaforte, T. (2017) Inhaled Nitric Oxide for Respiratory Failure in Preterm Infants. Cochrane Database of Systematic Reviews , 1, CD000509. https://doi.org/10.1002/14651858.CD000509.pub5
Hibbs, A.M., Walsh, M.C., Martin, R.J., et al. (2008) One-Year Respiratory Outcomes of Preterm Infants Enrolled in the Nitric Oxide (to Prevent) Chronic Lung Disease Trial. The Journal of Pediatrics , 153, 525-529. https://doi.org/10.1016/j.jpeds.2008.04.033
De Visser, Y.P., Walther, F.J., Laghmani, E.H., et al. (2009) Sildenafifil Attenuates Pulmonary Inflammation and Fifibrin Deposition, Mortality and Right Ventricular Hypertrophy in Neonatal Hyperoxic Lung Injury. Respiratory Research , 10, Article No. 30. https://doi.org/10.1186/1465-9921-10-30
Van Der Graaf, M., Rojer, L.A., Helbing, W.A., et al. (2019) Sildenafifil for Bronchopulmonary Dysplasia and Pulmonary Hypertension: A Meta-Analysis. Pulm o nary Circulation , 9, 1-8. https://doi.org/10.1177/2045894019837875
Ali, Z., Schmidt, P., Dodd, J. and Jeppesen, D.L. (2013) Bronchopulmonary Dysplasia: A Review. Archives of Gynecology and Obstetrics , 288, 325-333. https://doi.org/10.1007/s00404-013-2753-8
Araki, S., Kato, S., Namba, F., et al. (2018) Vitamin A to Prevent Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants: A Systematic Review and Meta-Analysis. PLOS ONE , 13, e0207730. https://doi.org/10.1371/journal.pone.0207730
Shenai, J.P., Chytil, F. and Stahlman, M.T. (1985) Vitamin A Status of Neonates with Bronchopulmonary Dysplasia. Pediatric Research , 19, 185-188. https://doi.org/10.1203/00006450-198502000-00007
Tyson, J.E., Wright, L.L. and Stahlman, M.T. (1999) Vitamin A Supplementation for Extremelylow-Birth-Weight Infants. National Institute of Child Health and Human Development Neonatal Research Network. The New England Journal of Medicine , 340, 1962-1968.
Rysavy, M.A., Li, L., Tyson, J.E., et al. (2021) Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial. The Journal of Pediatrics , 236, 78-85.E5. https://doi.org/10.1016/j.jpeds.2021.05.022
Garg, B.D., Bansal, A. and Kabra, N.S. (2019) Role of Vitamin A Supplementation in Prevention of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Neonates: A Systematic Review of Randomized Trials. The Journal of Mater nal-Fetal & Neonatal Medicine , 32, 2608-2615. https://doi.org/10.1080/14767058.2018.1441282
Falciglia, H.S., Johnson, J.R., Sullivan, J., et al. (2003) Role of Antioxidant Nutrients and Lipid Peroxidation in Premature Infants with Respiratory Distress Syndrome and Bronchopulmonary Dysplasia. American Journal of Perinatology , 20, 97-108. https://doi.org/10.1055/s-2003-38315
Vyas, J.R., Currie, A., Dunster, C., et al. (2001) Ascorbate Acid Concentration in Airways Lining Fluid from Infants Who Develop Chronic Lung Disease of Prematurity. European Journal of Pediatrics , 160, 177-184. https://doi.org/10.1007/s004310000709
Ofman, G. and Tipple, T.E. (2019) Antioxidants & Bronchopulmonary Dysplasia: Beating the System or Beating a Dead Horse? Free Radical Biology and Medicine , 142, 138-145. https://doi.org/10.1016/j.freeradbiomed.2019.01.038
Arigliani, M., Spinelli, A.M., Liguoro, I., et al. (2018) Nutrition and Lung Growth. Nutrients , 10, Article 919. https://doi.org/10.3390/nu10070919
Tindell, R. and Tipple, T. (2018) Selenium: Implications for Outcomes in Extremely Preterm Infants. Journal of Perinatology , 38, 197-202. https://doi.org/10.1038/s41372-017-0033-3
Mostafa-Gharehbaghi, M., Mostafa-Gharabaghi, P., Ghanbari, F., et al. (2012) Determination of Selenium in Serum Samples of Preterm Newborn Infants with Bronchopulmonary Dysplasia Using a Validated Hydride Generation System. Biological Trace Element Research , 147, 1-7. https://doi.org/10.1007/s12011-011-9270-z
Peirovifar, A., Gharehbaghi, M.M., Abdulmohammad-Zadeh, H., et al. (2013) Serum Selenium Levels of the Very Low Birth Weight Premature Newborn Infants with Bronchopulmonary Dysplasia. Journal of Trace Elements in Medicine and B i ology , 27, 317-321. https://doi.org/10.1016/j.jtemb.2013.03.006
Staub, E., Evers, K. and Askie, L.M. (2021) Enteral Zinc Supplementation for Prevention of Morbidity and Mortality in Preterm Neonates. Cochrane Database of Systematic Reviews , 12, CD012797. https://doi.org/10.1002/14651858.CD012797.pub2
Mathur, N.B. and Agarwal, D.K. (2015) Zinc Supplementation in Preterm Neonates and Neurological Development: A Randomized Controlled Trial. Indian Pediatrics , 52, 951-955. https://doi.org/10.1007/s13312-015-0751-6
Poggi, C. and Dani, C. (2014) Antioxidant Strategies and Respiratory Disease of the Preterm Newborn: An Update. Oxidative Medicine and Cellular Longevity , 2014, Article ID: 721043. https://doi.org/10.1155/2014/721043
Suleymanoglu, S., Çekmez, F., Cetinkaya, M., et al. (2014) Protective Effects of Melatonin Therapy in Model for Neonatal Hyperoxic Lung Injury. Alternative Ther a pies in Health and Medicine , 20, 24-29.
Lee, J.Y., Na, Q., Shin, N.E., et al. (2020) Melatonin for Prevention of Fetal Lung Injury Associated with Intrauterine Inflflammation and for Improvement of Lung Maturation. Journal of Pineal Research , 69, e12687. https://doi.org/10.1111/jpi.12687
Shawky Elfarargy, M., Adam Ali, D. and Al-Ashmawy, G.M. (2020) Melatonin Supplementation as Adjuvant Therapy for the Prevention of Brunchopulmonary Dysplasia in Neonates. Iranian Journal of Neonatology , 11, 85-90.
Dilli, D., Özyazici, A., Dursun, A., et al. (2017) Predictive Values of Plasma KL-6 in Bronchopulmonary Dysplasia in Preterm Infants. Turkish Journal of Medical Sciences , 47, 621-626. https://doi.org/10.3906/sag-1512-78
Barrington, K.J., Fortin-Pellerin, E. and Pennaforte, T. (2017) Fluid Restriction for Treatment of Preterm Infants with Chronic Lung Disease. Cochrane Database of Systematic Reviews , 2, CD005389. https://doi.org/10.1002/14651858.CD005389.pub2
Stewart, A. and Brion, L.P. (2011) Intravenous or Enteral Loop Diuretics for Preterm Infants with (or Developing) Chronic Lung Disease. Cochrane Database of Systematic Reviews , 9, CD001453. https://doi.org/10.1002/14651858.CD001453.pub2
Stewart, A.L. and Brion, L.P. (2011) Routine Use of Diuretics in Very-Low Birth-Weight Infants in the Absence of Supporting Evidence. Journal of Perinatology , 31, 633-634. https://doi.org/10.1038/jp.2011.44
Pacifici, G.M. (2012) Clinical Pharmacology of the Loop Diuretics Furosemide and Bumetanide in Neonates and Infants. Pediatric Drugs , 14, 233-246. https://doi.org/10.2165/11596620-000000000-00000
Johnson, A.K., Lynch, N., Newberry, D., et al. (2017) Impact of Diuretic Therapy in the Treatment of Bronchopulmonary Dysplasia and Acute Kidney Injury in the Neonatal Population. Advances in Neonatal Care , 17, 337-346. https://doi.org/10.1097/ANC.0000000000000427
Brion, L.P., Primhak, R.A. and Yong, W. (2006) Aerosolized Diuretics for Preterm Infants with (or Developing) Chronic Lung Disease. Cochrane Database of Syst e matic Reviews , 3, CD001694. https://doi.org/10.1002/14651858.CD001694.pub2
Viscardi, R.M. and Kallapur, S.G. (2015) Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. Clinics in Perinatology , 42, 719-738. https://doi.org/10.1016/j.clp.2015.08.003
Wang, E.E.L., Ohlsson, A. and Kellner, J.D. (1995) Association of Ureaplasma Urealyticum Colonization with Chronic Lung Disease of Prematurity: Results of a Metaanalysis. The Journal of Pediatrics , 127, 640-644. https://doi.org/10.1016/S0022-3476(95)70130-3
Ballard, H.O., Anstead, M.I. and Shook, L.A. (2007) Azithromycin in the Extremely Low Birth Weight Infant for the Prevention of Bronchopulmonary Dysplasia: A Pilot Study. Respiratory Research , 8, Article No. 41. https://doi.org/10.1186/1465-9921-8-41
Nair, V., Loganathan, P. and Soraisham, A.S. (2014) Azithromycin and Other Macrolides for Prevention of Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis. Neonatology , 106, 337-347. https://doi.org/10.1159/000363493
Viscardi, R.M., Terrin, M.L., Magder, L.S., et al. (2020) Randomised Trial of Azithromycin to Eradicate Ureaplasma in Preterm Infants. ADC Fetal & Neonatal Ed i tion , 105, 615-622. https://doi.org/10.1136/archdischild-2019-318122
Balany, J. and Bhandari, V. (2015) Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia. Frontiers in Medicine , 2, Article 90. https://doi.org/10.3389/fmed.2015.00090
Lapcharoensap, W., Kan, P., Powers, R.J., et al. (2017) The Relationship of Nosocomial Infection Reduction to Changes in Neonatal Intensive Care Unit Rates of Bronchopulmonary Dysplasia. The Journal of Pediatrics , 180, 105-109.E1. https://doi.org/10.1016/j.jpeds.2016.09.030
Ting, J.Y., Synnes, A., Roberts, A., et al. (2016) Association between Antibiotic Use and Neonatal Mortality and Morbidities in Very Low-Birth-Weight Infants without Culture-Proven Sepsisor Necrotizing Enterocolitis. JAMA Pediatr ics , 170, 1181-1187. https://doi.org/10.1001/jamapediatrics.2016.2132
Van Haaften, T., Byrne, R., Bonnet, S., et al. (2009) Airway Delivery of Mesenchymal Stem Cells Prevents Arrested Alveolar Growth in Neonatal Lung Injury in Rats. American Journal of Respiratory and Critical Care Medicine , 180, 1131-1142. https://doi.org/10.1164/rccm.200902-0179OC
Tong, Y., Zuo, J. and Yue, D. (2021) Application Prospects of Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia and the Challenges Encountered. BioMed Research International , 2021, Article ID: 9983664. https://doi.org/10.1155/2021/9983664
Batsali, A.K., Kastrinaki, M.C., Papadaki, H.A., et al. (2013) Mesenchymal Stem Cells Derived from Wharton’s Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications. Current Stem Cell Research & Therapy , 8, 144-155. https://doi.org/10.2174/1574888X11308020005
Pierro, M., Ionescu, L., Montemurro, T., et al. (2013) Short-Term, Long-Term and Paracrine Effect of Human Umbilical Cord-Derived Stem Cells in Lung Injury Prevention and Repair in Experimental Bronchopulmonary Dysplasia. Thorax , 68, 475-484. https://doi.org/10.1136/thoraxjnl-2012-202323
Chang, Y.S., Ahn, S.Y., Yoo, H.S., et al. (2014) Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial. The Journal of Pediatrics , 164, 966-972.E6. https://doi.org/10.1016/j.jpeds.2013.12.011
Ahn, S.Y., Chang, Y.S., Kim, J.H., et al. (2017) Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. The Journal of Pediatrics , 185, 49-54.E2. https://doi.org/10.1016/j.jpeds.2017.02.061
Ahn, S.Y., Chang, Y.S., Lee, M.H., et al. (2021) Stem Cells for Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Controlled Phase II Trial. Stem Cells Translational Medicine , 10, 1129-1137. https://doi.org/10.1002/sctm.20-0330
Poonyagariyagorn, H.K., Metzger, S., Dikeman, D., et al. (2014) Superoxide Dismutase 3 Dysregulation in a Murine Model of Neonatal Lung Injury. American Journal of Respiratory Cell and Molecular Biology , 51, 380-390. https://doi.org/10.1165/rcmb.2013-0043OC
Rosenfeld, W., Evans, H., Concepcion, L., et al. (1984) Prevention of Bronchopulmonary Dysplasia by Administration of Bovine Superoxide Dismutase in Preterm Infants with Respiratory Distress Syndrome. The Journal of Pediatrics , 105, 781-785. https://doi.org/10.1016/S0022-3476(84)80307-8
Davis, J.M., Parad, R.B., Michele, T., et al. (2003) Pulmonary Outcome at 1 Year Corrected Age in Premature Infants Treated at Birth with Recombinant Human CuZn Superoxide Dismutase. Pediatrics , 111, 469-476. https://doi.org/10.1542/peds.111.3.469
Solling, C. (2012) Organ-Protective and Immunomodulatory Effects of Erythropoietin an Update on Recent Clinical Trials. Basic & Clinical Pharmacology & To x icology , 110, 113-121. https://doi.org/10.1111/j.1742-7843.2011.00820.x
Luan, Y., Zhang, L., Chao, S., et al. (2016) Mesenchymal Stem Cells in Combination with Erythropoietin Repair Hyperoxia-Induced Alveoli Dysplasia Injury in Neonatal Mice via Inhibition of TGF-Beta1 Signaling. Oncotarget , 7, 47082-47094. https://doi.org/10.18632/oncotarget.9314
Ananthan, A., Balasubramanian, H., Rao, S. and Patole, S. (2018) Clinical Outcomes Related to the Gastrointestinal Trophic Effffects of Erythropoietin in Preterm Neonates: A Systematic Review and Meta-Analysis. Advances in Nutrition , 9, 238-246. https://doi.org/10.1093/advances/nmy005
Mandell, E.W., Kratimenos, P., Abman, S.H., et al. (2019) Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clinics in Perinatology , 46, 291-310. https://doi.org/10.1016/j.clp.2019.02.011
Hellström, A., Engström, E., Hård, A.L., et al. (2003) Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated with Retinopathy of Prematurity and Other Complications of Premature Birth. Pediatrics , 112, 1016-1020. https://doi.org/10.1542/peds.112.5.1016
Yang, K. and Dong, W. (2020) Perspectives on Probiotics and Bronchopulmonary Dysplasia. Frontiers in Pediatrics , 8, Article 570247. https://doi.org/10.3389/fped.2020.570247
Tan, J.Y., Tang, Y.C. and Huang, J. (2020) Gut Microbiota and Lung Injury. A d vances in Experimental Medicine and Biology , 1238, 55-72. https://doi.org/10.1007/978-981-15-2385-4_5
Illiano, P., Brambilla, R. and Parolini, C. (2020) The Mutual Interplay of Gut Microbiota, Diet and Human Disease. The FEBS Journal , 287, 833-855. https://doi.org/10.1111/febs.15217
Lal, C.V., Travers, C., Aghai, Z.H., et al. (2016) the Airway Microbiome at Birth. Scientific Reports , 6, Article No. 31023. https://doi.org/10.1038/srep31023
Ryan, F.J., Drew, D.P., Douglas, C., et al. (2019) Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary Dysplasia. mSystems , 4, E00484-19. https://doi.org/10.1128/mSystems.00484-19
Chen, S.M., Lin, C.P. and Jan, M.S. (2020) Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case-Control Study. American Journal of Perinatology , 38, 1142-1149. https://doi.org/10.1055/s-0040-1710554
Cantey, J.B., Huffffman, L.W., Subramanian, A., et al. (2016) Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. The Journal of Pediatrics , 181, 289-293.E1. https://doi.org/10.1016/j.jpeds.2016.11.002